PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin

Cell Death Dis. 2018 Sep 12;9(9):931. doi: 10.1038/s41419-018-0981-3.

Abstract

RHO GTPases regulate essential functions such as the organization of the actin cytoskeleton. The classic members cycle between an active GTP-bound and an inactive GDP-bound conformation whereas atypical members are predominantly GTP-bound. Besides their well-established role, the classic RHO GTPases RHOB and RAC1, are rapidly induced and/or activated by genotoxic stress and contribute to the DNA damage response. Here we used camptothecin, a selective topoisomerase I (TOP1) inhibitor that stabilizes TOP1 cleavage complexes (TOP1cc), to search for other potential early DNA damage-inducible RHO GTPase genes. We identified that an atypical RHO GTPase, RND1, is rapidly induced by camptothecin. RND1 induction is closely associated with the presence of TOP1cc induced by camptothecin or by DNA lesions that elevate TOP1cc levels such as UV and hydrogen peroxide. We further demonstrated that camptothecin increases RND1 gene transcription and mRNA stability. Camptothecin also increases poly(ADP-ribose) polymerase 1 (PARP-1) activity, whose inhibition reduces RND1 transcription. In addition, overexpression of RND1 increases PARP-1, suggesting a cross-talk between PARP-1 and RND1. Finally, RND1 protects cells against camptothecin-induced apoptosis, and hence favors cellular resistance to camptothecin. Together, these findings highlight RND1 as an atypical RHO GTPase early induced by TOP1cc, and show that the TOP1cc-PARP-1-RND1 pathway protects cells against apoptosis induced by camptothecin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Camptothecin / pharmacology*
  • Cell Line
  • Cell Line, Tumor
  • DNA / genetics*
  • DNA Damage / drug effects
  • DNA Damage / genetics
  • DNA Topoisomerases, Type I / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • HCT116 Cells
  • Humans
  • Melanoma, Experimental / drug therapy
  • Melanoma, Experimental / genetics
  • Mice
  • NIH 3T3 Cells
  • Poly (ADP-Ribose) Polymerase-1 / genetics*
  • Poly(ADP-ribose) Polymerase Inhibitors / pharmacology
  • Topoisomerase I Inhibitors / pharmacology
  • Transcription, Genetic / genetics*
  • rho GTP-Binding Proteins / genetics*

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • Topoisomerase I Inhibitors
  • DNA
  • Poly (ADP-Ribose) Polymerase-1
  • rho GTP-Binding Proteins
  • DNA Topoisomerases, Type I
  • Camptothecin